{"id":"W4390021910","doi":"10.1016/s2352-3026(23)00338-1","title":"Oral decitabine–cedazuridine versus intravenous decitabine for myelodysplastic syndromes and chronic myelomonocytic leukaemia (ASCERTAIN): a registrational, randomised, crossover, pharmacokinetics, phase 3 study","year":2023,"lang":"en","type":"article","venue":"The Lancet Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"ca_institutions":"Health Sciences Centre; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Hôpital Maisonneuve-Rosemont; University of Alberta; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; Ottawa Hospital; University of Ottawa","funders":"Astex Pharmaceuticals","keywords":"Decitabine; Medicine; Chronic myelomonocytic leukemia; Myelodysplastic syndromes; Azacitidine; Internal medicine; International Prognostic Scoring System; Adverse effect; Oncology; Pharmacology; Bone marrow","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001372139,0.0004708518,0.001814678,0.0003172843,0.0004222344,0.00009114875,0.0005231801,0.0001893938,0.0001578899],"category_scores_gemma":[0.002550843,0.000343808,0.000150094,0.0008291274,0.0006888512,0.0001145883,0.0002545564,0.0006314144,0.0001382776],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005146258,"about_ca_system_score_gemma":0.001015539,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006514793,"about_ca_topic_score_gemma":0.0001136673,"domain_scores_codex":[0.9964586,0.0002843992,0.0007522846,0.000767894,0.0004990918,0.001237737],"domain_scores_gemma":[0.9948056,0.003470493,0.0002252227,0.0008621403,0.0003441972,0.0002923343],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5951656,0.004354703,0.005519867,0.006113825,0.008833014,0.01741872,0.006180983,0.002176213,0.02696179,0.01893115,0.276428,0.03191625],"study_design_scores_gemma":[0.8679723,0.013552,0.005296642,0.000280741,0.003006905,0.008903063,0.002057588,0.07182059,0.004175074,0.001831344,0.01988642,0.001217317],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9843653,0.001325572,0.0007005899,0.00790766,0.0005417292,0.004452673,0.0001127431,0.0003036151,0.0002901339],"genre_scores_gemma":[0.9953622,0.0009354356,0.0004473622,0.0002992739,0.0008624794,0.001000287,0.0002644621,0.00009865654,0.0007298532],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2728068,"threshold_uncertainty_score":0.9999014,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09378879086140673,"score_gpt":0.4066840908216205,"score_spread":0.3128952999602138,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}